Vivos Therapeutics strikes $12 million stock deal for SOD Sciences stake
Vivos will acquire an 11% fully diluted equity interest in SOD Sciences
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →